Literature DB >> 19458904

Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR.

David A Boltz1, Bounlom Douangngeun, Settha Sinthasak, Phouvong Phommachanh, Phetlamphone Midouangchanh, David Walker, Rachael Keating, Alexey M Khalenkov, Mahesh Kumar, Robert G Webster.   

Abstract

Despite the extensive use of poultry vaccines to control the spread of H5N1 influenza in poultry, H5N1 outbreaks continue to occur in domestic birds. Our objective was to determine the duration of the neutralizing antibody response under field conditions after vaccination with a laboratory-tested inactivated reverse genetics-derived H5N3 vaccine. H5N3 hemagglutination inhibition (HI) and virus neutralization (VN) antibodies were observed 40 weeks after vaccination of chickens with two doses and vaccination of ducks with one dose. Cross-clade antibodies to an H5N1 virus (A/chicken/Laos/A0464/07) antigenically distinct from the vaccine strain were detected in ducks after a single vaccination and were sustained for 28 weeks (for 40 weeks when a boost vaccination was given). Our results indicate that this inactivated H5N3 vaccine can produce long-lasting antibodies to homologous and heterologous viruses under field conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458904      PMCID: PMC3133597          DOI: 10.1007/s00705-009-0385-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  33 in total

1.  Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.

Authors:  D E Swayne; M Garcia; J R Beck; N Kinney; D L Suarez
Journal:  Vaccine       Date:  2000-01-06       Impact factor: 3.641

2.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

3.  Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus.

Authors:  Chang-Won Lee; Dennis A Senne; David L Suarez
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics.

Authors:  Ming Liu; John M Wood; Trevor Ellis; Scott Krauss; Patrick Seiler; Christie Johnson; Erich Hoffmann; Jennifer Humberd; Diane Hulse; Yun Zhang; Robert G Webster; Daniel R Perez
Journal:  Virology       Date:  2003-09-30       Impact factor: 3.616

5.  Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.

Authors:  Jeong-Ki Kim; Patrick Seiler; Heather L Forrest; Alexey M Khalenkov; John Franks; Mahesh Kumar; William B Karesh; Martin Gilbert; R Sodnomdarjaa; Bounlom Douangngeun; Elena A Govorkova; Robert G Webster
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

6.  Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission.

Authors:  Trevor M Ellis; Connie Y H C Leung; Mary K W Chow; Lucy A Bissett; William Wong; Yi Guan; J S Malik Peiris
Journal:  Avian Pathol       Date:  2004-08       Impact factor: 3.378

7.  Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine.

Authors:  Jeanet A van der Goot; Michiel van Boven; Arjan Stegeman; Sandra G P van de Water; Mart C M de Jong; Guus Koch
Journal:  Virology       Date:  2008-10-09       Impact factor: 3.616

8.  Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.

Authors:  Norikazu Isoda; Yoshihiro Sakoda; Noriko Kishida; Kosuke Soda; Saori Sakabe; Ryuichi Sakamoto; Takashi Imamura; Masashi Sakaguchi; Takashi Sasaki; Norihide Kokumai; Toshiaki Ohgitani; Kazue Saijo; Akira Sawata; Junko Hagiwara; Zhifeng Lin; Hiroshi Kida
Journal:  Arch Virol       Date:  2008-07-25       Impact factor: 2.574

9.  Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.

Authors:  Angela Römer-Oberdörfer; Jutta Veits; Dorothee Helferich; Thomas C Mettenleiter
Journal:  Vaccine       Date:  2008-03-18       Impact factor: 3.641

10.  Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007.

Authors:  Tien Dung Nguyen; The Vinh Nguyen; Dhanasekaran Vijaykrishna; Robert G Webster; Yi Guan; J S Malik Peiris; Gavin J D Smith
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

View more
  3 in total

Review 1.  Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.

Authors:  David E Swayne; Erica Spackman; Mary Pantin-Jackwood
Journal:  Ecohealth       Date:  2013-09-12       Impact factor: 3.184

2.  Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.

Authors:  Jefferson J S Santos; Adebimpe O Obadan; Stivalis Cardenas Garcia; Silvia Carnaccini; Darrell R Kapczynski; Mary Pantin-Jackwood; David L Suarez; Daniel R Perez
Journal:  Vaccine       Date:  2017-09-06       Impact factor: 3.641

3.  Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.

Authors:  Walid H Kilany; Marwa Safwat; Samy M Mohammed; Abdullah Salim; Folorunso Oludayo Fasina; Olubunmi G Fasanmi; Azhar G Shalaby; Gwenaelle Dauphin; Mohammed K Hassan; Juan Lubroth; Yilma M Jobre
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.